Xerox Holdings Corporation
NASDAQ:XRXBusiness Equipment & Supplies
-$0.07 today
- Market cap
- $117.20M
- Beta
- 2.44
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$8.09
- Dividend yield
- 3.25%
Volume 13.53M
Average 6.32M
XRX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Xerox Holdings CorporationNASDAQ: XRX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $64M rose 120.7% year over year, ahead of the +40.4% change in trailing-twelve-month research & development. Sequentially, it fell 9.9% from the prior quarter. Over 3 fiscal years it compounded at -8.9% a year.
Context
- Research & development amounted to 3.3% of revenue in FY2025, up 0.2 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +120.7% holds above the trailing-twelve-month pace of +40.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 230M USD
- Year-over-year change
- +20.4%
- 4-year CAGR
- -7.2%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 230M | +20.4% |
| FY2024 | 2024-12-31 | 191M | -16.6% |
| FY2023 | 2023-12-31 | 229M | -24.7% |
| FY2022 | 2022-12-31 | 304M | -1.9% |
| FY2021 | 2021-12-31 | 310M | — |
Research & Development vs competitors
How XRX compares with its peers on the latest reported figures
- XRX's LTM Mar 2026 research & development of $240M is the 3rd highest of the 7 companies compared; the peer median is $57.95M.
- Its year-over-year change of +40.4% is the highest of 5, against a peer median of -1.0%.
- Research & development amounts to 3.2% of revenue for XRX, versus a peer median of 2.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $1.61B | +0.9% | -1.0% | 2.7% | |
| LTM Mar 2026 | $347.04M | +4.6% | +4.5% | 9.5% | |
| LTM Mar 2026 | $240M | +40.4% | -8.9% | 3.2% | |
| LTM Jun 2026 | $83.9M | -8.3% | -11.5% | 2.2% | |
| LTM Mar 2026 | $32M | -3.0% | -1.0% | 2.9% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding XRX) | $57.95M | -1.0% | -1.0% | 2.4% | |
Competitors are the stored peer set for XRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 7.04B | 7.11B | 6.89B | 6.22B | 7.02B |
| Cost of Revenue | 4.64B | 4.79B | 4.57B | 4.26B | 5.12B |
| Gross Profit | 2.4B | 2.32B | 2.31B | 1.96B | 1.9B |
| Gross Margin | 34.1% | 32.6% | 33.6% | 31.5% | 27.1% |
| Research & Development | 310M | 304M | 229M | 191M | 230M |
| Selling, General & Admin | 1.72B | 1.76B | 1.7B | 1.54B | 1.64B |
| Operating Expenses | 2.08B | 2.11B | 1.96B | 1.8B | 1.96B |
| Depreciation & Amortization | 327M | 270M | 251M | 274M | 331M |
| EBITDA | (49M) | 36M | 291M | (822M) | 91M |
| EBITDA Margin | -0.7% | 0.5% | 4.2% | -13.2% | 1.3% |
| Operating Income | 320M | 212M | 353M | 159M | (56M) |
| Operating Margin | 4.5% | 3.0% | 5.1% | 2.6% | -0.8% |
| Interest Income | 4M | 11M | 16M | 14M | 14M |
| Interest Expense | 96M | 91M | 68M | 119M | 248M |
| Other Income / Expenses | (792M) | (537M) | (381M) | (1.38B) | (432M) |
| Income Before Tax | (472M) | (325M) | (28M) | (1.22B) | (488M) |
| Pre-Tax Margin | -6.7% | -4.6% | -0.4% | -19.5% | -6.9% |
| Income Tax Expense | (17M) | (3M) | (29M) | 105M | 541M |
| Net Income | (455M) | (322M) | 1M | (1.32B) | (1.03B) |
| Net Margin | -6.5% | -4.5% | 0.0% | -21.2% | -14.7% |
| EPS (Basic) | (2.56) | (2.15) | (0.09) | (10.75) | (8.25) |
| EPS (Diluted) | (2.56) | (2.15) | (0.09) | (10.75) | (8.25) |
| Weighted Avg Shares | 183.17M | 156.01M | 149.12M | 124.21M | 126.47M |
| Weighted Avg Shares (Diluted) | 183.17M | 156.01M | 149.12M | 124.21M | 126.47M |
Xerox Holdings Corporation
NASDAQ:XRX
Intrinsic Alpha fair value
Locked
Current Price
$0.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.